1D2B

THE MMP-INHIBITORY, N-TERMINAL DOMAIN OF HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-1 (N-TIMP-1), SOLUTION NMR, 29 STRUCTURES

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_15N-SEPARATED_NOESY	0.5 MM N-TIMP-1 U-15N		0.171	6.0	AMBIENT	293
2	3D TIME-SHARED NOESY-(13C,15N)-HSQC	0.9 MM N-TIMP-1 U-15N,13C		0.171	6.0	AMBIENT	293
3	3D 13C FSCT-HSMQC-NOESY	0.9 MM N-TIMP-1 U-15N,13C		0.171	6.0	AMBIENT	293
4	3D 13C NOESY-HMQC	0.7 MM N-TIMP-1 U-15N,13C		0.171	6.0	AMBIENT	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	500

NMR Refinement
Method	Details	Software
TORSION ANGLE DYNAMICS FOLLOWED BY CARTESIAN SIMULATED ANNEALING	Model 22 is closest to the average while Model 3 represents the conformer with the fewest violations	CNS

NMR Ensemble Information
Conformer Selection Criteria	STRUCTURES WITH THE LEAST RESTRAINT VIOLATIONS,STRUCTURES WITH THE LOWEST ENERGY
Conformers Calculated Total Number	120
Conformers Submitted Total Number	29

Additional NMR Experimental Information
Details	3D HNHB, 3D HACAHB-COSY, 2D HMQC-J, 3D COUPLED HCACO, 3D HNCA-J, {15N} SPIN- ECHO DIFFERENCE 13C CT-HSQC, {13CO} SPIN-ECHO DIFFERENCE 13C CT-HSQC, 2D HN(CG) , 2D HN(COCG), 15N IPAP-HSQC, 3D 13CA-COUPLED HNCO, 13C'-COUPLED IN-PHASE 15N HSQC

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	SYBYL TRIAD	V6.2 OR V.6.3	TRIPOS INS., ST. LOUIS, MO
2	structure solution	CNS	0.6	BRUNGER,A.T., ADAMS,P.D., CLORE,G.M., WARREN,G.L.
3	refinement	CNS	0.6	BRUNGER,A.T., ADAMS,P.D., CLORE,G.M., WARREN,G.L.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.